Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Donghai Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2118-2523; OpenAlex author ID A5103145918. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Pralatrexate mediates effective killing of gemcitabine-resistant pancreatic cancer: role of mTOR/4E-BP1 signal pathway. Last author DOI 10.1016/j.heliyon.2022.e12064↗
  2. COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer. Co-author DOI 10.3892/ijo.2019.4825↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kwabena Gyabaah Owusu-Ansah · 2 shared papers, 2019–2022 · strength 0.28
  2. Shusen Zheng · 2 shared papers, 2019–2022 · strength 0.28
  3. Wan-Wen Weng · 1 shared paper, 2022 · strength 0.19
  4. Jiawei Hong · 1 shared paper, 2022 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.